BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, April 29, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Other news to note for Feb. 20, 2026

Feb. 20, 2026
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Angiodynamics, Briacell, Briapro, Cassava, Catheter Precision, Devonian, Johnson & Johnson, Senseonics, Sequel.
Read More

In the clinic for Feb. 20, 2026

Feb. 20, 2026
Clinical updates for biopharma and med tech, including data readouts and publications: Avidity, Merck, Myriad Generics, Traws, Viiv, Yoltech.
Read More

Financings for Feb. 20, 2026

Feb. 20, 2026
Biopharma and med-tech companies raising money in public or private financings, including: 20/20 Biolabs, Altesa, Compass, Elumn8, Envoy, Eupraxia, Medical 21, Moleculin, Oncopeptides, Resverlogix, Sift, Starget, Ten63.
Read More

Appointments and advancements for Feb. 20, 2026

Feb. 20, 2026
New hires and promotions in the biopharma and med-tech industries, including: Artiva, Ataibeckley, Fize, Integrated, Novabridge, Phio, Reacta.
Read More

Regulatory actions for Feb. 19, 2026

Feb. 19, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Affinia, Biomerica, Hardy, Helsinn, Immunitybio, Instanosis, Johnson & Johnson, Moderna, NG, Sandoz, Shield, Spruce, Telix.
Read More

Other news to note for Feb. 19, 2026

Feb. 19, 2026
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Axol, Izotropic, Newcells, Rasayana, Stoked, Theriva.
Read More

In the clinic for Feb. 19, 2026

Feb. 19, 2026
Clinical updates for biopharma and med tech, including data readouts and publications: Aprea, Eli Lilly, Moleculin, Neurosense, Novartis, PLL, Zealand.
Read More

Financings for Feb. 19, 2026

Feb. 19, 2026
Biopharma and med-tech companies raising money in public or private financings, including: Appili, EIR, HCW, Korsana, Prosomnus, Senzime, Synchrony, Tele Genomics.
Read More

Appointments and advancements for Feb. 19, 2026

Feb. 19, 2026
New hires and promotions in the biopharma and med-tech industries, including: Aquestive, Aspargo, Cranius, Eyepoint, Immorta, Integra, Lixte, Liora, Tarsus, Tenvie.
Read More

Regulatory actions for Feb. 18, 2026

Feb. 18, 2026
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Accord, Bio-Techne, Bio-Thera, BMS, Cytokinetics, Deciphera, Disc, Eisai, GSK, Harmony, Johnson & Johnson, Kane, Lex, Moderna, Nicox, Novo Nordisk, Nrx, Ono, Retia Medical, Stada, Valneva.
Read More
Previous 1 2 … 28 29 30 31 32 33 34 35 36 … 1787 1788 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 28, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 28, 2026
  • Silhouette of head, brain

    Plasticity, properly parsed, provides psychiatric platform

    BioWorld
    If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
  • Roche identifies new TREM2 agonists

    BioWorld Science
    F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
  • Three red darts on target

    Sun Pharma to acquire Merck spinoff Organon for $11.75B

    BioWorld
    Sun Pharmaceuticals Industries Ltd. will pay $11.75 billion cash to acquire Organon & Co. The transaction is expected to close in early 2027. The addition of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing